Ryan DeMasi

1.9k citations
31 papers · 1.1k · 2 hit papers · h-index 14

Impact in

    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
    • Spondyloarthritis Studies and Treatments
  • Hematology top 5%
    • Autoimmune and Inflammatory Disorders Research

Papers in

    • Rheumatoid Arthritis Research and Therapies 28
    • Spondyloarthritis Studies and Treatments 2
    • Systemic Lupus Erythematosus Research 2
    • Autoimmune and Inflammatory Disorders Research 10

Ryan DeMasi

30 papers receiving 1.1k citations

Ryan DeMasi's Hit Papers

Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study 2019 · 245 citations
2450+3+6Years since publication100200300

Peers

Ryan DeMasi
Comparison fields: 5 of 73
  • Rheumatology 689
  • Hematology 214
  • Oncology 186
  • Immunology 137
  • Genetics 66
Replace Jennifer Hodge with:
Jennifer Hodge United States
Christina Dickson United States
Daniela Graham United States
CK Lee South Korea
Ivana Vranić United Kingdom
Allison Luo United States
Candice Low Ireland
J.M. Kremer United States
Michael A. Maldonado United States
J Lysholm Sweden
Ryan DeMasi relative to Jennifer Hodge United States Jennifer Hodge's profile →
Citations per field
00.5×
Jennifer Hodge · 1×
Citations per year

Countries citing papers authored by Ryan DeMasi

Since Specialization
Citations

This map shows the geographic impact of Ryan DeMasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan DeMasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan DeMasi more than expected).

Fields of papers citing papers by Ryan DeMasi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan DeMasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan DeMasi. The network helps show where Ryan DeMasi may publish in the future.

Co-authors

The 25 scholars most cited alongside Ryan DeMasi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ryan DeMasi Line = papers co-authored together Ryan DeMasi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials
Hit paper breakdown →
2017306
2
Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study
Hit paper breakdown →
2019245
3 201671
4 201963
5 201862
6 201860
7 201940
8 201037
9 201931
10 201829
11 201626
12 201822
13 202021
14 202013
15 201811
16 20188
17 20187
18 20177
19 20226
20 20185

About Ryan DeMasi

Ryan DeMasi is a scholar working on Rheumatology, Hematology, Genetics, Immunology and Infectious Diseases, having authored 31 papers that have together received 1.1k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (28 papers), Autoimmune and Inflammatory Disorders Research (10 papers), Chronic Lymphocytic Leukemia Research (6 papers), Biosimilars and Bioanalytical Methods (3 papers), Spondyloarthritis Studies and Treatments (2 papers), Systemic Lupus Erythematosus Research (2 papers), HIV/AIDS drug development and treatment (1 paper) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Rheumatology (689 citations), Hematology (214 citations), Oncology (186 citations), Immunology (137 citations) and Genetics (66 citations). Ryan DeMasi has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Kenneth Kwok, Lisy Wang, Stanley Cohen, Jeffrey R. Curtis, J. Wollenhaupt, Christina Charles‐Schoeman, Koshika Soma, Sander Strengholt, Ketti K. Terry and Joel C. Silverfield. Their work appears in journals such as Annals of the Rheumatic Diseases, Arthritis Care & Research, RMD Open, Lara D. Veeken and Arthritis & Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact